| UniProt ID | PK3C3_HUMAN | |
|---|---|---|
| UniProt AC | Q8NEB9 | |
| Protein Name | Phosphatidylinositol 3-kinase catalytic subunit type 3 | |
| Gene Name | PIK3C3 {ECO:0000312|HGNC:HGNC:8974} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 887 | |
| Subcellular Localization | Midbody . Late endosome . Cytoplasmic vesicle, autophagosome . As component of the PI3K complex I localized to pre-autophagosome structures. As component of the PI3K complex II localized predominantly to endosomes (Probable). Localizes also to discre | |
| Protein Description | Catalytic subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and required for the abcission step in cytokinesis, probably in the context of PI3KC3-C2. [PubMed: 20643123] | |
| Protein Sequence | MGEAEKFHYIYSCDLDINVQLKIGSLEGKREQKSYKAVLEDPMLKFSGLYQETCSDLYVTCQVFAEGKPLALPVRTSYKAFSTRWNWNEWLKLPVKYPDLPRNAQVALTIWDVYGPGKAVPVGGTTVSLFGKYGMFRQGMHDLKVWPNVEADGSEPTKTPGRTSSTLSEDQMSRLAKLTKAHRQGHMVKVDWLDRLTFREIEMINESEKRSSNFMYLMVEFRCVKCDDKEYGIVYYEKDGDESSPILTSFELVKVPDPQMSMENLVESKHHKLARSLRSGPSDHDLKPNAATRDQLNIIVSYPPTKQLTYEEQDLVWKFRYYLTNQEKALTKFLKCVNWDLPQEAKQALELLGKWKPMDVEDSLELLSSHYTNPTVRRYAVARLRQADDEDLLMYLLQLVQALKYENFDDIKNGLEPTKKDSQSSVSENVSNSGINSAEIDSSQIITSPLPSVSSPPPASKTKEVPDGENLEQDLCTFLISRACKNSTLANYLYWYVIVECEDQDTQQRDPKTHEMYLNVMRRFSQALLKGDKSVRVMRSLLAAQQTFVDRLVHLMKAVQRESGNRKKKNERLQALLGDNEKMNLSDVELIPLPLEPQVKIRGIIPETATLFKSALMPAQLFFKTEDGGKYPVIFKHGDDLRQDQLILQIISLMDKLLRKENLDLKLTPYKVLATSTKHGFMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYILGVGDRHLDNLLLTKTGKLFHIDFGYILGRDPKPLPPPMKLNKEMVEGMGGTQSEQYQEFRKQCYTAFLHLRRYSNLILNLFSLMVDANIPDIALEPDKTVKKVQDKFRLDLSDEEAVHYMQSLIDESVHALFAAVVEQIHKFAQYWRK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 25 | Phosphorylation | NVQLKIGSLEGKREQ EEEEEECCCCCHHHH | 27.07 | 19369195 | |
| 29 | Acetylation | KIGSLEGKREQKSYK EECCCCCHHHHHHHH | 43.30 | 560012611 | |
| 29 | Ubiquitination | KIGSLEGKREQKSYK EECCCCCHHHHHHHH | 43.30 | - | |
| 34 | Acetylation | EGKREQKSYKAVLED CCHHHHHHHHHHHCC | 31.40 | 19413330 | |
| 36 | Ubiquitination | KREQKSYKAVLEDPM HHHHHHHHHHHCCCC | 38.83 | - | |
| 36 | Methylation | KREQKSYKAVLEDPM HHHHHHHHHHHCCCC | 38.83 | 115974985 | |
| 96 | Ubiquitination | EWLKLPVKYPDLPRN HHCCCCCCCCCCCCC | 49.48 | - | |
| 109 | Phosphorylation | RNAQVALTIWDVYGP CCCEEEEEEEECCCC | 15.41 | 30576142 | |
| 114 | Phosphorylation | ALTIWDVYGPGKAVP EEEEEECCCCCCEEC | 18.35 | 30576142 | |
| 125 | Phosphorylation | KAVPVGGTTVSLFGK CEECCCCEEEEHHHH | 20.35 | 21406692 | |
| 126 | Phosphorylation | AVPVGGTTVSLFGKY EECCCCEEEEHHHHC | 16.04 | 21406692 | |
| 128 | Phosphorylation | PVGGTTVSLFGKYGM CCCCEEEEHHHHCCH | 18.85 | 21406692 | |
| 132 | Ubiquitination | TTVSLFGKYGMFRQG EEEEHHHHCCHHHCC | 31.15 | - | |
| 132 | Acetylation | TTVSLFGKYGMFRQG EEEEHHHHCCHHHCC | 31.15 | 25953088 | |
| 133 | Phosphorylation | TVSLFGKYGMFRQGM EEEHHHHCCHHHCCC | 17.75 | 30576142 | |
| 144 | Ubiquitination | RQGMHDLKVWPNVEA HCCCCCCCCCCCCCC | 48.59 | - | |
| 158 | Ubiquitination | ADGSEPTKTPGRTSS CCCCCCCCCCCCCCC | 64.54 | 21906983 | |
| 159 | Phosphorylation | DGSEPTKTPGRTSST CCCCCCCCCCCCCCC | 33.19 | 20513426 | |
| 163 | Phosphorylation | PTKTPGRTSSTLSED CCCCCCCCCCCCCHH | 32.70 | 20513426 | |
| 164 | Phosphorylation | TKTPGRTSSTLSEDQ CCCCCCCCCCCCHHH | 21.69 | 20513426 | |
| 165 | Phosphorylation | KTPGRTSSTLSEDQM CCCCCCCCCCCHHHH | 32.52 | 28857561 | |
| 168 | Phosphorylation | GRTSSTLSEDQMSRL CCCCCCCCHHHHHHH | 38.93 | - | |
| 179 | Phosphorylation | MSRLAKLTKAHRQGH HHHHHHHHHHHHCCC | 26.02 | 26437602 | |
| 207 | Phosphorylation | EIEMINESEKRSSNF HHEECCCCHHCCCCC | 43.88 | 22210691 | |
| 209 | Ubiquitination | EMINESEKRSSNFMY EECCCCHHCCCCCEE | 67.85 | - | |
| 229 | Ubiquitination | RCVKCDDKEYGIVYY EEEECCCCEEEEEEE | 39.31 | - | |
| 231 | Phosphorylation | VKCDDKEYGIVYYEK EECCCCEEEEEEEEE | 20.21 | 27642862 | |
| 238 | Ubiquitination | YGIVYYEKDGDESSP EEEEEEEECCCCCCC | 51.38 | - | |
| 243 | Phosphorylation | YEKDGDESSPILTSF EEECCCCCCCEEEEE | 46.27 | 29255136 | |
| 244 | Phosphorylation | EKDGDESSPILTSFE EECCCCCCCEEEEEE | 17.57 | 19664994 | |
| 248 | Phosphorylation | DESSPILTSFELVKV CCCCCEEEEEEEEEC | 31.90 | 29255136 | |
| 249 | Phosphorylation | ESSPILTSFELVKVP CCCCEEEEEEEEECC | 17.18 | 29255136 | |
| 261 | Phosphorylation | KVPDPQMSMENLVES ECCCCCCCHHHHHHH | 20.07 | 19369195 | |
| 268 | Phosphorylation | SMENLVESKHHKLAR CHHHHHHHHHHHHHH | 29.79 | 17494752 | |
| 269 | Ubiquitination | MENLVESKHHKLARS HHHHHHHHHHHHHHH | 35.90 | - | |
| 276 | Phosphorylation | KHHKLARSLRSGPSD HHHHHHHHHHCCCCC | 23.64 | 24719451 | |
| 279 | Phosphorylation | KLARSLRSGPSDHDL HHHHHHHCCCCCCCC | 61.42 | 23186163 | |
| 282 | Phosphorylation | RSLRSGPSDHDLKPN HHHHCCCCCCCCCCC | 51.61 | 30108239 | |
| 287 | Ubiquitination | GPSDHDLKPNAATRD CCCCCCCCCCCCCHH | 42.13 | - | |
| 287 | Methylation | GPSDHDLKPNAATRD CCCCCCCCCCCCCHH | 42.13 | - | |
| 305 | Phosphorylation | IIVSYPPTKQLTYEE EEEECCCCCCCCHHH | 27.24 | - | |
| 310 | Phosphorylation | PPTKQLTYEEQDLVW CCCCCCCHHHHHHHH | 26.51 | - | |
| 321 | Phosphorylation | DLVWKFRYYLTNQEK HHHHHHHHHHHCHHH | 13.13 | 23403867 | |
| 322 | Phosphorylation | LVWKFRYYLTNQEKA HHHHHHHHHHCHHHH | 11.64 | 23403867 | |
| 324 | Phosphorylation | WKFRYYLTNQEKALT HHHHHHHHCHHHHHH | 20.80 | 23403867 | |
| 328 | Ubiquitination | YYLTNQEKALTKFLK HHHHCHHHHHHHHHH | 38.64 | - | |
| 346 | Ubiquitination | WDLPQEAKQALELLG CCCCHHHHHHHHHHC | 35.04 | - | |
| 379 | Phosphorylation | TNPTVRRYAVARLRQ CCHHHHHHHHHHHHC | 8.55 | - | |
| 395 | Phosphorylation | DDEDLLMYLLQLVQA CHHHHHHHHHHHHHH | 12.29 | - | |
| 412 | Ubiquitination | YENFDDIKNGLEPTK CCCHHHHHCCCCCCC | 52.54 | - | |
| 448 | Phosphorylation | DSSQIITSPLPSVSS CHHHEECCCCCCCCC | 17.65 | 17192257 | |
| 452 | Phosphorylation | IITSPLPSVSSPPPA EECCCCCCCCCCCCC | 42.17 | 22199227 | |
| 454 | Phosphorylation | TSPLPSVSSPPPASK CCCCCCCCCCCCCCC | 41.27 | 22199227 | |
| 455 | Phosphorylation | SPLPSVSSPPPASKT CCCCCCCCCCCCCCC | 38.99 | 17192257 | |
| 460 | Phosphorylation | VSSPPPASKTKEVPD CCCCCCCCCCCCCCC | 46.78 | 22199227 | |
| 463 | Ubiquitination | PPPASKTKEVPDGEN CCCCCCCCCCCCCCC | 61.52 | - | |
| 488 | Phosphorylation | SRACKNSTLANYLYW HHHHCCCHHHHHEEE | 39.00 | - | |
| 513 | Phosphorylation | TQQRDPKTHEMYLNV CCCCCCCHHHHHHHH | 28.58 | 18187866 | |
| 517 | Phosphorylation | DPKTHEMYLNVMRRF CCCHHHHHHHHHHHH | 7.67 | 18187866 | |
| 525 | Phosphorylation | LNVMRRFSQALLKGD HHHHHHHHHHHHCCC | 16.84 | 20873877 | |
| 534 | Phosphorylation | ALLKGDKSVRVMRSL HHHCCCHHHHHHHHH | 21.64 | 24260401 | |
| 547 | Phosphorylation | SLLAAQQTFVDRLVH HHHHHHHHHHHHHHH | 17.34 | 22210691 | |
| 557 | Acetylation | DRLVHLMKAVQRESG HHHHHHHHHHHHHCC | 52.33 | 25953088 | |
| 582 | Ubiquitination | ALLGDNEKMNLSDVE HHHCCCCCCCCCCCE | 39.07 | - | |
| 600 | Ubiquitination | LPLEPQVKIRGIIPE CCCCCCCEEEEECHH | 22.80 | - | |
| 613 | Methylation | PETATLFKSALMPAQ HHHHHHHHHHHCEEE | 37.62 | 115974993 | |
| 617 | Sulfoxidation | TLFKSALMPAQLFFK HHHHHHHCEEEEEEE | 2.30 | 21406390 | |
| 624 | Acetylation | MPAQLFFKTEDGGKY CEEEEEEECCCCCEE | 43.61 | 19413330 | |
| 625 | Phosphorylation | PAQLFFKTEDGGKYP EEEEEEECCCCCEEE | 33.87 | 19413330 | |
| 630 | Ubiquitination | FKTEDGGKYPVIFKH EECCCCCEEEEEEEC | 52.49 | 2189047 | |
| 631 | Phosphorylation | KTEDGGKYPVIFKHG ECCCCCEEEEEEECC | 13.15 | 24719451 | |
| 666 | Ubiquitination | RKENLDLKLTPYKVL HHCCCCCCCCCCEEE | 50.40 | - | |
| 668 | Phosphorylation | ENLDLKLTPYKVLAT CCCCCCCCCCEEEEE | 24.00 | 20513426 | |
| 670 | Phosphorylation | LDLKLTPYKVLATST CCCCCCCCEEEEECC | 14.43 | 20049867 | |
| 706 | Ubiquitination | SIQNFFRKYAPSENG HHHHHHHHHCCCCCC | 40.38 | - | |
| 771 | Acetylation | YILGRDPKPLPPPMK CCCCCCCCCCCCCCC | 64.57 | 560012599 | |
| 781 | Ubiquitination | PPPMKLNKEMVEGMG CCCCCCCHHHHCCCC | 58.59 | - | |
| 781 | Acetylation | PPPMKLNKEMVEGMG CCCCCCCHHHHCCCC | 58.59 | 560012605 | |
| 790 | Phosphorylation | MVEGMGGTQSEQYQE HHCCCCCCCHHHHHH | 24.16 | 26437602 | |
| 795 | Phosphorylation | GGTQSEQYQEFRKQC CCCCHHHHHHHHHHH | 13.12 | 24114839 | |
| 803 | Phosphorylation | QEFRKQCYTAFLHLR HHHHHHHHHHHHHHH | 9.90 | - | |
| 840 | Sumoylation | LEPDKTVKKVQDKFR CCCCCHHHHHHHHHC | 53.08 | - | |
| 840 | Sumoylation | LEPDKTVKKVQDKFR CCCCCHHHHHHHHHC | 53.08 | - | |
| 845 | Sumoylation | TVKKVQDKFRLDLSD HHHHHHHHHCCCCCH | 18.45 | - | |
| 845 | Sumoylation | TVKKVQDKFRLDLSD HHHHHHHHHCCCCCH | 18.45 | - | |
| 884 | Phosphorylation | QIHKFAQYWRK---- HHHHHHHHHHC---- | 12.07 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 159 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
| 159 | T | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| 163 | T | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
| 165 | S | Phosphorylation | Kinase | AMPK | Q9Y478 | Uniprot |
| 249 | S | Phosphorylation | Kinase | ULK1 | O75385 | PSP |
| 249 | S | Phosphorylation | Kinase | ULK2 | Q8IYT8 | PSP |
| 249 | S | Phosphorylation | Kinase | ULK3 | Q6PHR2 | PSP |
| 668 | T | Phosphorylation | Kinase | CDK5 | Q00535 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | KLHL20 | Q9Y2M5 | PMID:26687681 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PK3C3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PK3C3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PI3R4_HUMAN | PIK3R4 | physical | 20562859 | |
| UVRAG_HUMAN | UVRAG | physical | 20562859 | |
| BAKOR_HUMAN | ATG14 | physical | 20562859 | |
| CLP1L_HUMAN | CLPTM1L | physical | 20562859 | |
| NRBF2_HUMAN | NRBF2 | physical | 20562859 | |
| BECN1_HUMAN | BECN1 | physical | 20562859 | |
| RUBIC_HUMAN | KIAA0226 | physical | 20562859 | |
| UBP11_HUMAN | USP11 | physical | 20562859 | |
| BECN1_HUMAN | BECN1 | physical | 21936852 | |
| BECN1_HUMAN | BECN1 | physical | 18628207 | |
| MYH9_HUMAN | MYH9 | physical | 23569248 | |
| MYH1_HUMAN | MYH1 | physical | 23569248 | |
| KIF1B_HUMAN | KIF1B | physical | 23569248 | |
| DREB_HUMAN | DBN1 | physical | 23569248 | |
| TIF1B_HUMAN | TRIM28 | physical | 23569248 | |
| HS90A_HUMAN | HSP90AA1 | physical | 23569248 | |
| GRP78_HUMAN | HSPA5 | physical | 23569248 | |
| ANM5_HUMAN | PRMT5 | physical | 23569248 | |
| BECN1_HUMAN | BECN1 | physical | 18843052 | |
| UVRAG_HUMAN | UVRAG | physical | 18843052 | |
| BAKOR_HUMAN | ATG14 | physical | 18843052 | |
| BAKOR_HUMAN | ATG14 | physical | 19050071 | |
| BECN1_HUMAN | BECN1 | physical | 19050071 | |
| PI3R4_HUMAN | PIK3R4 | physical | 26344197 | |
| UBP18_HUMAN | USP18 | physical | 25906440 | |
| BECN1_HUMAN | BECN1 | physical | 28757208 | |
| PI3R4_HUMAN | PIK3R4 | physical | 28757208 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-25; THR-163; SER-165;SER-244; SER-261; SER-452; SER-454 AND SER-455, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244; SER-448 ANDSER-455, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-625, AND MASSSPECTROMETRY. | |